ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression (Q34519896)
scientific article
Language:
Current Data About ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
(P31) (Q13442814)
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P304) 774-782
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P478) 94
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P577) Saturday, December 1, 2001
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P921) (Q61643320)
(P887)

(P1433) (Q332492)
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P1476) "ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression" (language: en)
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P2093) N G Anderson
(P1545) 1
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

T Ahmad
(P1545) 2
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

K Chan
(P1545) 3
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

R Dobson
(P1545) 4
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

N J Bundred
(P1545) 5
(P248)
(P698) 11745477
(P813) Wednesday, August 2, 2017

(P2860) (Q29617919)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q28293442)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q33597396)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q33886341)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q36326248)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q40630247)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q33808352)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q36292824)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q30176334)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q41751003)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q41173912)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q24685138)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q48046157)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q37365431)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q28297412)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q28368373)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q40908491)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q42492007)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q41887619)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q43548699)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q41054513)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

(Q42825534)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FIJC.1557
(P813) Sunday, January 21, 2018

other details
description scientific article

External Links
(P356) 10.1002/IJC.1557
(P698) 11745477
(P5875) 11612361